sitoiStock-184990117.jpg

2021

Prenestini A., Sartirana M., Lega F.,
Involving clinicians in management: assessing views of doctors and nurses on hybrid professionalism in clinical directorates
BMC Health Services Reseach 21: 350 (link)

 

Armeni P, Cavazza M, Xoxi E, Taruscio D, Kodra Y
Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
International Journal of Environmental Research and Public Health 18(3):1101 (link)


Galeone C, Bruzzi P, Jommi C
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system
BMJ Open 13;11(1):e041259 (link)



Jommi C, Armeni P, Bertolani A, Costa F, Otto M
The Future of Funds for Innovative Medicines: results froma Delphi Study
Global & Regional Health Technology Assessment 8:22-8 (link)



Ronco V., Dilecce M, Lanati E, Canonico PL, Jommi C
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
Journal of Pharmaceutical Policy and Practice 14, 30 (2021). (link)



Jommi C, Armeni P, Bertolani A, Costa F, Otto M
The Future of Funds for Innovative Medicines: results froma Delphi Study
Global & Regional Health Technology Assessment 8:22-8 (link)



Chiumente M, Russi A, Todino F, Mengato D, Coppola M, Rivano M, Palozzo A, Jommi C
Preparation of intravenous chemotherapy bags: evalutation of a dose banding approach in an Italian oncology hospital
Global & Regional Health Technology Assessment 8:29-34 (link)



Whittal A, Meregaglia M, Nicod E
The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessement
The Patient — Patient-Centered Outcomes Research  (link)